Tag Archives: startup

RESI Innovation Challenge: Meet The Asia-Based Startups That Took The Top Spots At RESI Boston Summer

7 Jun

By Jessica Yang, Investor Research Analyst, LSN

On June 4th, more than 700 scientist-entrepreneurs and investors entered the exhibition hall at Boston Marriott Copley Place to participate in the RESI conference. They were greeted by 30 Innovation Challenge finalists across therapeutics, medical device, diagnostics, and digital health sectors. The 30 companies, evaluated by LSN’s expert system and scientific & commercial review team, competed directly on merits of innovation and commercial viability. We wish all our finalists the best in bringing their products forward toward commercialization, but there could only be 3 top prize winners.

First Prize: Taiwan Resonant Waves Research Corp.

Taiwan Resonant Waves Research Corp. (TRWR) was founded in 2010 in the capital of Taiwan – Taipei. Integrating innovative bioelectronic technology with non-invasive medical devices, we are dedicated to helping patients with chronic diseases better manage health-related challenges.There is unlimited promise in the application of Bioelectrical medicine in the treatment of chronic diseases. Designed and developed by TRWR, Microcurrent Electrical Nerve Stimulation technology (MENS) is currently being used as a non-invasive, physical approach to treating and alleviating symptoms associated with diabetes (such as decreasing HbA1c of Type 2 Diabetes Mellitus patient). Our vision is to lead the world in groundbreaking research and development in electroceutical technology as a means of enhancing quality of life, without the adverse side effects of conventional approaches.

Natasha Eldridge, Director of RESI Conference Series, LSN | Lucy Parkinson, Director of Investor Research, LSN | Chris Chen, Business Development, TRWR | Ann Chiu, COO, TRWR | Kuo-Chuan Huang, Doctor, TRWR

Second Prize: The Wave Talk

Our laser-based sensor is many times more accurate than conventional laser and is able to detect even low concentrations of bacteria based on its movements in real-time. Even though our first application targets water, we have managed to decrease antibiotics susceptibility test from 10-15 hours to less than 1 hour.

Natasha Eldridge, Director of RESI Conference Series, LSN | Lucy Parkinson, Director of Investor Research, LSN | SeungA LEE, Marketing, UX, The Wave Talk | YoungDug Kim, CEO & Founder, The Wave Talk

Third Prize: Taipeibio

Taipeibio is an R&D-driven company with core technology derived from Harvard and MIT; which focuses on tissue regeneration and repairs various bone defects including alveolar bone, bone, joint, ligament and cartilage. Taipeibio has comprehensive global IP protection in over 45 countries (Fish & Richardson; Cesari & McKenna). Taipeibio has established 3 core labs and 5 research arms to support product development with 2 governmental funding programs . Taipeibio has accumulated over 160 successful clinical cases with 14 years stress-bearing data to prove safety and efficacy. The cartilage regeneration product has been proved to repair large articular cartilages and difficult TMJ defects in a rabbit model. Relative scientific reports were published in high-impact SCI journals. The products will be made in U.S.A. and aiming FDA approval.

Natasha Eldridge, Director of RESI Conference Series, LSN | Lucy Parkinson, Director of Investor Research, LSN | Dr. Thomas Wen-Fu Lai, TaipeiBio | Jim-Pei Chu, CEO, TaipeiBio

It is worth mentioning that the proportion of Asia-based startups at RESI is the highest it’s ever been. LSN worked closely with both Development Center of Biotechnology (DCB) from Taiwan and Korea Trade-Investment Promotion Agency (KOTRA).  Of the over 100 startups that applied to be finalists in the RESI Innovation Challenge, more than 30% were from Taiwan or Korea.  This is also the first time that Asia-based companies won all three top prizes. The first and third place winners were two Medtech companies from Taiwan, Taiwan Resonant Waves Research Corp and TaipeiBio respectively. The second place winner was THE WAVE TALK, one of the Korea-based companies sponsored by KOTRA. Check out how RESI collaborates with KOTRA.

Building a Life Science Startup Community on Linkedin

1 Mar

By Sean Tran, Business Development Manager, LSN

Life Science Nation (LSN) just revamped its LinkedIn profile in an effort to help life science startups engage with potential investors! With the growing impact of social media, we aim to create another avenue to build connections with early-stage life science players and offer content relevant to our growing community.

On the primary LSN profile, we will post the hottest investor mandates from our LSN Database, latest news about the life science industry, and updates on the Redefining Early Stage Investment (RESI) conference series.

LSN has also created a separate RESI Conference group on LinkedIn to help past and new attendees stay connected with one another. Through this channel, members can promote their companies, announce updates on the development of their technologies, build relationships with other like-minded members, and collectively move the needle in the life sciences.

We hope you will connect with us and help us build a startup community that can make an impact on the life science industry!

Please click here to explore and follow our page.

Key Stakeholders Share the Value of RESI for Early Stage Investors and Startups

27 Apr

By Natasha Eldridge, RESI Conference Manager, LSN

natasha-wp-new

In San Diego on June 19th, the Redefining Early Stage Investments (RESI) Conference will bring a new, early stage focused discussion venue for startups and investors who are visiting BIO week and want more opportunities to connect. What makes RESI different? At our last event, RESI on MaRS in Toronto, we asked our key stakeholders this question and here’s what they told us.

Ying Tam – Head of Digital Health – MaRS Discovery District

“All the research says that one of the critical elements for an entrepreneur ecosystem, especially in health, is funding and investment. It takes a long time to nurture a health company, to get it to market and commercialization and scale. So, investment is critical for the development of a startup in health. RESI brings in a whole set of investors from across North America and across the world.”

Rebecca Yu – Head of JLABS @ TorontoJohnson & Johnson Innovation JLABS

“RESI attracts many repeat attendees, and that speaks to me that there’s a story, there’s something here. There’s great stuff happening here for entrepreneurs. There’s early stage companies from across Canada, from pharmaceuticals to medical devices to consumer health, and of course there’s a big digital health and AI presence here in Toronto. That’s why JLABS and J&J are here. We play in all the sectors, we partner with different groups within this ecosystem, and we see LSN/RESI as a key partner as well, to bring investors to this ecosystem.”

Richard Soll – Senior Vice President, International Discovery Service Unit – WuXi AppTec

“The RESI conference is an opportunity to help out these early stage companies such that they can achieve inflection points. If I can identify companies early, then I might become a vendor of choice for them. Getting in early becomes an important objective for me. When I come to a conference like RESI, I come to these early stage companies who are really looking for partnering with investors here, but also get an opportunity to introduce WuXi to them as well.”

RESI attendees can book up to 16 meetings with investors in one day, right at the start of BIO Week. If you want to take this opportunity to start your BIO with a bang, register now.

Get Your Startup in the Spotlight at the RESI Innovation Challenge in San Diego

20 Apr

By Shaoyu Chang, MD, MPH, Director of Research & Asia Business Development Liaison, LSN

Shaoyu 10*10

RESI is going to BIO. As we join 2017’s largest life science innovation carnival, we aim to showcase the most promising, innovative new health technologies in the RESI Innovation Challenge. If you’re headed to San Diego with the aim of raising money or making deals for your startup, we’d like to see your application.

The RESI Innovation Challenge covers startups in therapeutics, medtech, diagnostics and healthcare IT companies from around the globe. All applicants will be vetted based on not only the quality of the company’s scientific work, but also the strength of the management team and how well-positioned the company is to receive investment.

On June 19th, RESI’s estimated 1000 attendees will receive “RESI Cash” to allocate to the entrepreneurs whose technologies they expect will be most influential. The capital invested will be tallied up and the top three winners will receive prizes and be featured in our RESI newsletter recap that will go out to LSN’s 20,000 newsletter readership. See below for the previous RESI Innovation Challenge first place winners – a diverse group of startups from every area of the life sciences.

Michael Quigley, VP of Market Research, Life Science Nation | Mark Elias, CEO, Co-founder, Steadiwear | Emile Maamary, CFO, Co-founder, Steadiwear | Natasha Eldridge, Marketing Manager – RESI Conference, Life Science Nation

RESI on MaRS 2017 Innovation Challenge 1st Place Winner – Steadiwear inc.

What makes the RESI Innovation Challenge so valuable?  We’ve included a few words from previously successful participants below, but in short, being part of the Innovation Challenge provides startups with a new way to get attention and start dialogues with the investors who attend RESI. Participants can share their message all day in the exhibit hall, with their Innovation Challenge display providing a starting point for a meaningful conversation about the opportunity.

APPLICATION DEADLINE: May 5, 2017

Here is what our previous winners are saying about the RESI Innovation Challenge:

DSC00392

“It was an absolute pleasure to participate in the RESI conference held at MaRS in Toronto. The unique structure of the conference facilitated creating new relationships with potential investors and partners. In particular, the Innovation Challenge pushed us to introduce ourselves to new people, which will be useful as we look towards a future financing round. I definitely recommend the RESI conferences to entrepreneurs seeking financing in the bio / health space.”
 

– Raymond Shih, President, Co-Founder, QoC Health

3rd Place, RESI on MaRS, June 23, 2016

02

“The RESI Innovation Challenge is a really good opportunity to meet investors and other companies in the space.  It’s a good showcase to reach that audience.”

– Jessica Ching, CEO, Eve Medical

2nd Place, RESI San Francisco, January 12, 2016

“The RESI Innovation Challenge is a unique way to pitch, and provides a great opportunity to see what other companies are doing in the industry, while allowing you to meet with potential investors and strategic partners outside of the partnering meetings.”

– John Connolly, VP Corporate Development, Rna Diagnostics

1st Place, RESI Boston, September 16, 2015

30 Leading Life Science Startups Compete in Innovation Challenge at The Redefining Early Stage Investments (RESI) Conference at MaRS

9 Mar

By Michael Quigley, VP of Market Research, LSN

mike-2

As RESI gears up for its second landing on MaRs in Toronto this April 4th we are proud to announce our latest batch of life science/health tech companies that will be participating in the RESI Innovation Challenge.

30 companies from across North America, hand selected by LSN’s scientific and commercial review team, will compete directly on merits of innovation and commercial viability.  Past RESI events have seen as many as 50% of innovation challenge contestants go on to receive funding or significant partnerships within a year from the competition.

From companies helping to detect oncoming seizures to those developing cost effective ways of growing blood stem cells, this diverse class of competitors is sure to impress. Come check them our yourself in the Exhibition Hall at RESI on MaRs on April 4th!

Therapeutic
 
Diagnostic
Medical Device
 
Healthcare IT
 

Compelling New Technology Startups Selected RESI@JPM Innovation Challenge

29 Dec

By Dennis Ford, Founder & CEO, LSN

The 11th Redefining Early Stage Investments (RESI) Conference will be joining the JPM fray for our largest event yet on January 10th in San Francisco. We’re excited to announce the early stage life science companies that will be participating in the RESI Innovation Challenge.

The 30 participating companies have been hand-selected by LSN’s scientific review committee based on the innovative nature of their core technology and how well-positioned each is to capitalize on their respective market opportunities.

Therapeutics
 
Digital Health
 

Diagnostics
 

Medtech Devices
 

Compelling New Technology Startups Selected, RESI X Innovation Challenge

18 Aug

By Dennis Ford, CEO of LSN; Creator of RESI Conference Series

As RESI comes back to Boston for its 10th conference, we’re excited to announce the early stage life science companies that will be participating in the event’s RESI Innovation Challenge.

The 30 participating companies have been hand-selected by LSN’s scientific review committee based on the innovative nature of their core technology and how well-positioned each is to capitalize on their respective market opportunities. The selected companies, two thirds of which have received funding from various NIH institutes, cover all corners of the life science domain including therapeutics, medtech, diagnostics and digital health.

Therapeutics

ADT-500t Duophos-500t Laurent-Pharmaceuticals-500t
Mitochondrial-Substrate-Invention-500t Novoron-500t PrimeVax-500t
SignalRx-500t

Technology Platform

Diagnostics

Medical Device

Digital Health

%d bloggers like this: